Jun Qi

26.3k total citations · 4 hit papers
177 papers, 9.3k citations indexed

About

Jun Qi is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Jun Qi has authored 177 papers receiving a total of 9.3k indexed citations (citations by other indexed papers that have themselves been cited), including 132 papers in Molecular Biology, 47 papers in Hematology and 31 papers in Oncology. Recurrent topics in Jun Qi's work include Protein Degradation and Inhibitors (86 papers), Multiple Myeloma Research and Treatments (36 papers) and Ubiquitin and proteasome pathways (35 papers). Jun Qi is often cited by papers focused on Protein Degradation and Inhibitors (86 papers), Multiple Myeloma Research and Treatments (36 papers) and Ubiquitin and proteasome pathways (35 papers). Jun Qi collaborates with scholars based in United States, China and United Kingdom. Jun Qi's co-authors include James E. Bradner, Andrew L. Kung, Junwei Shi, Christopher R. Vakoc, Scott J. Rodig, Johannes Zuber, Agustin Chicas, Harald Herrmann, Meredith J. Taylor and Edward Allan R. Sison and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Jun Qi

166 papers receiving 9.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia

2011 1.4k citations Jun Qi, James E. Bradner et al. profile →
The dTAG system for immediate and target-specific protein degradation

2018 652 citations Matthew A. Lawlor, Jennifer A. Perry et al. profile →
Discovery and Characterization of Super-Enhancer-Associated Dependencies in Diffuse Large B Cell Lymphoma

2013 550 citations Charles Y. Lin, Jun Qi et al. profile →
Targeting MYCN in Neuroblastoma by BET Bromodomain Inhibition

2013 457 citations Alexandre Puissant, Stacey M. Frumm et al. Cancer Discovery profile →

Peers

Countries citing papers authored by Jun Qi

Since Specialization

Citations

This map shows the geographic impact of Jun Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Qi more than expected).

Fields of papers citing papers by Jun Qi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Qi. The network helps show where Jun Qi may publish in the future.

Co-authorship network of co-authors of Jun Qi

This figure shows the co-authorship network connecting the top 25 collaborators of Jun Qi. A scholar is included among the top collaborators of Jun Qi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun Qi. Jun Qi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comprehensive insights into the mechanism of flavor formation in mandarin fish (Siniperca chuatsi) with inoculated fermentation 2025 ·Food Chemistry ·Kaihua Guo, Bin Hu, Yi Jiang, Zengyong Li, Jun Qi, Man‐Man Yu	1
2	Low-Temperature NO ₂ Sensor Based on ZnO/MWCNT Heterostructures for Intelligent Agriculture 2025 ·ACS Sensors ·Jun Qi, Ruren Xu, Y. N. Liu, (unknown), (unknown), Li Lv, Guangliang Cui, Pinhua Zhang	0
3	Exploration of the tunability of BRD4 degradation by DCAF16 trans-labelling covalent glues 2024 ·European Journal of Medicinal Chemistry ·Muhammad Murtaza Hassan, Yen-Der Li, W Michelle, Mingxing Teng, Woong Sub Byun, Kedar Puvar, Ryan J. Lumpkin, Brittany Sandoval, Justine C. Rutter, Cyrus Y. Jin, Michelle Wang, (unknown), Anna M. Schmoker, (unknown), Brian J. Groendyke, Jun Qi, Eric S. Fischer, Benjamin L. Ebert, Nathanael S. Gray	12
4	Identifying regulators of aberrant stem cell and differentiation activity in colorectal cancer using a dual endogenous reporter system 2024 ·Nature Communications ·Sándor Spisák, David J. Chen, (unknown), (unknown), Zhixin Li, (unknown), Laura Vízkeleti, Viktória Tisza, Pushpamali De Silva, Marios Giannakis, Brian M. Wolpin, Jun Qi, Nilay S. Sethi	5
5	Batoclimab as an add‐on therapy in neuromyelitis optica spectrum disorder patients with acute attacks 2022 ·European Journal of Neurology ·Yuge Wang, Xiaonan Zhong, Honghao Wang, (unknown), Fu‐Dong Shi, Dongmei Jia, Huan Yang, Qiuming Zeng, Chao Quan, Jingzi ZhangBao, Michael Lee, Jun Qi, Xiaoxiang Chen, Wei Qiu, (unknown)	13
6	Bivalent BET Bromodomain Inhibitors Confer Increased Potency and Selectivity for BRDT via Protein Conformational Plasticity 2022 ·Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), (unknown), Norbert Berndt, Jun Qi, Gunda I. Georg, E. Schönbrunn	12
7	Effects of nanoparticle-mediated Co-delivery of bFGF and VEGFA genes to deep burn wounds: An in vivo study 2021 ·Colloids and Surfaces B Biointerfaces ·(unknown), (unknown), Liang Feng, Lei Wang, Jun Qi, (unknown), You Lang Zhou, (unknown), Yi Zhang	15
8	Dynamic Chromatin Targeting of BRD4 Stimulates Cardiac Fibroblast Activation 2019 ·Circulation Research ·Matthew S. Stratton, Rushita A. Bagchi, Marina Barreto Felisbino, Rachel Hirsch, (unknown), Andrew S. Riching, (unknown), Keith A. Koch, Maria A. Cavasin, Michael Alexanian, Kunhua Song, Jun Qi, Madeleine E. Lemieux, Deepak Srivastava, Maggie P. Y. Lam, Saptarsi M. Haldar, Charles Y. Lin, Timothy A. McKinsey	123
9	YAP1-Mediated Suppression of USP31 Enhances NFκB Activity to Promote Sarcomagenesis 2018 ·Cancer Research ·Shuai Ye, Matthew A. Lawlor, (unknown), Shaun Egolf, (unknown), (unknown), Gabrielle E. Ciotti, (unknown), Gloria E. Marino, Jennifer Shah, (unknown), Kristy Weber, Paul M.C. Park, Md. Zahidul Alam, Alison Grazioli, Malay Haldar, Mousheng Xu, Jennifer A. Perry, Jun Qi, T.S. Karin Eisinger‐Mathason	45
10	Mechanism, Consequences, and Therapeutic Targeting of Abnormal IL15 Signaling in Cutaneous T-cell Lymphoma 2016 ·Cancer Discovery ·Anjali Mishra, Krista La Perle, (unknown), Laura A. Sullivan, (unknown), (unknown), (unknown), Jing Wen, Kathleen McConnell, Jun Qi, Henry K. Wong, Giandomenico Russo, Jianying Zhang, Guido Marcucci, James E. Bradner, Pierluigi Porcu, Michael A. Caligiuri	75
11	Bromodomain and Extraterminal Protein Inhibitor JQ1 Suppresses Thyroid Tumor Growth in a Mouse Model 2016 ·Clinical Cancer Research ·Xuguang Zhu, Keisuke Enomoto, Li Zhao, Yuelin J. Zhu, Mark C. Willingham, Paul Meltzer, Jun Qi, Sheue-yann Cheng	44
12	Chronic Myelogenous Leukemia– Initiating Cells Require Polycomb Group Protein EZH2 2016 ·Cancer Discovery ·Huafeng Xie, Cong Peng, Jialiang Huang, Bin E. Li, W. Ray Kim, Elenoe C. Smith, Yuko Fujiwara, Jun Qi, Giulia Cheloni, Partha Pratim Das, Minh Nguyen, Shaoguang Li, James E. Bradner, Stuart H. Orkin	73
13	Selective Inhibition of HDAC1 and HDAC2 as a Potential Therapeutic Option for B-ALL 2015 ·Clinical Cancer Research ·Matthew C. Stubbs, Won-Il Kim, (unknown), Tina Davis, Sridhar Vempati, (unknown), Matthew D. Witkin, Jun Qi, Andrei V. Krivtsov, James E. Bradner, Andrew L. Kung, Scott A. Armstrong	59
14	Highly Active Combination of BRD4 Antagonist and Histone Deacetylase Inhibitor against Human Acute Myelogenous Leukemia Cells 2014 ·Molecular Cancer Therapeutics ·Warren Fiskus, Sunil Sharma, Jun Qi, John A. Valenta, (unknown), Bhavin Shah, (unknown), Bryce P. Portier, Melissa Rodríguez, Santhana G.T. Devaraj, Ming Zhan, Jianting Sheng, Swaminathan P. Iyer, James E. Bradner, Kapil N. Bhalla	155
15	BET Protein Antagonist JQ1 Is Synergistically Lethal with FLT3 Tyrosine Kinase Inhibitor (TKI) and Overcomes Resistance to FLT3-TKI in AML Cells Expressing FLT-ITD 2014 ·Molecular Cancer Therapeutics ·Warren Fiskus, Sunil Sharma, Jun Qi, Bhavin Shah, Santhana G.T. Devaraj, Christopher Leveque, Bryce P. Portier, Swaminathan P. Iyer, James E. Bradner, Kapil N. Bhalla	112
16	Syntheses and Discovery of a Novel Class of Cinnamic Hydroxamates as Histone Deacetylase Inhibitors by Multimodality Molecular Imaging in Living Subjects 2014 ·Cancer Research ·Carmel T. Chan, Jun Qi, William Smith, (unknown), Ralph Mazitschek, Nathan West, Robert E. Reeves, Gabriela Chiosis, Stuart L. Schreiber, James E. Bradner, Ramasamy Paulmurugan, Sanjiv S. Gambhir	12
17	Targeting STAT5 in Hematologic Malignancies through Inhibition of the Bromodomain and Extra-Terminal (BET) Bromodomain Protein BRD2 2014 ·Molecular Cancer Therapeutics ·Suhu Liu, Sarah R. Walker, Erik A. Nelson, (unknown), Michael Xiang, Patricia A. Toniolo, Jun Qi, Richard M. Stone, Martha Wadleigh, James E. Bradner, David A. Frank	51
18	RapidCaP, a Novel GEM Model for Metastatic Prostate Cancer Analysis and Therapy, Reveals Myc as a Driver of Pten -Mutant Metastasis 2014 ·Cancer Discovery ·Hyejin Cho, Tali Herzka, Zheng Wu, Jun Qi, John E. Wilkinson, James E. Bradner, Brian D. Robinson, Mireia Castillo-Martín, Carlos Cordon‐Cardo, Lloyd C. Trotman	68
19	Targeting MYCN in Neuroblastoma by BET Bromodomain Inhibition breakdown → 2013 ·Cancer Discovery ·Alexandre Puissant, Stacey M. Frumm, Gabriela Alexe, Christopher F. Bassil, Jun Qi, Yvan H. Chanthery, Erin A. Nekritz, Rhamy Zeid, W. Clay Gustafson, Patricia Greninger, Matthew J. Garnett, Ultan McDermott, Cyril H. Benes, Andrew L. Kung, William A. Weiss, James E. Bradner, Kimberly Stegmaier	457
20	Efficacy of BET Bromodomain Inhibition in Kras-Mutant Non–Small Cell Lung Cancer 2013 ·Clinical Cancer Research ·Takeshi Shimamura, Zhao Chen, Margaret Soucheray, Julián Carretero, Eiki Kikuchi, Jeremy H. Tchaicha, Yandi Gao, Katherine A. Cheng, Travis J. Cohoon, Jun Qi, Esra A. Akbay, Alec C. Kimmelman, Andrew L. Kung, James E. Bradner, Kwok‐Kin Wong	158

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact